AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)

AVAN 10.04

0.0%

Jun 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Roger Bodine who wrote (378)	2/20/2002 4:25:55 PM
From: rrufff	Read Replies (1) of 513

Looks like there might be a little excitement. Here's one guy who still likes it: (from Briefing.com) Avant Immunotherapeutics Reiterated `Strong Buy' at Ladenburg By Sybil Carlson Princeton, New Jersey, Feb. 20 (Bloomberg Data) -- Avant Immunotherapeutics Inc. (AVAN US) was reiterated ``strong buy'' by analyst Albert L Rauch at Ladenburg Thalmann & Co. The 12-month target price was cut to $7.00 per share from $10.00 per share. The CC hinted that insiders would be buying after earnings quiet period. BTW I'll take 7 instead of 10 LOL.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next